Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
If you're looking for a high-yield dividend stock in the healthcare sector, you might be interested in comparing Takeda Pharmaceutical (NYSE: TAK) and (NASDAQ: VTRS).
Both companies offer attractive dividends, but which one is a better buy right now? Let's take a closer look at their financial performance, growth prospects, valuation, and dividend sustainability to find out.
Image source: Getty Images.
Source Fool.com
Viatris Inc. Stock
€10.85
1.580%
The community is currently still undecided about Viatris Inc. with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 12 € shows a slightly positive potential of 10.6% compared to the current price of 10.85 € for Viatris Inc..
